Zdravlje a.d.
Kiren L. Naidoo is an accomplished executive with extensive experience in the pharmaceutical and financial sectors. Currently serving as the Chief Executive Officer at Zdravlje Leskovac since April 2021, Naidoo also co-founded and holds the position of Managing Director at Frontier Pharma, where expertise in pharmaceutical investments spans Europe, the Middle East, and Africa. Formerly a Vice President at Merrill Lynch from February 2007 to January 2016, Naidoo specialized in healthcare investment banking, contributing to significant M&A and capital markets transactions totaling billions in value. Educational background includes a Bachelor of Business Science in Finance from the University of Cape Town.
This person is not in any teams
This person is not in any offices
Zdravlje a.d.
Pharmaceutical and Chemical Industry Zdravlje Leskovac is a leader in the Balkan pharmaceutical industry. Zdravlje, which is a Serbian word for “Health”, has a 70-year-long history of manufacturing first-class pharmaceutical products at the highest international standards. From April the 1st 2021, Zdravlje continues its journey as an independent pharmaceutical company under the ownership of Frontier Pharma and Baystone Group, highly experienced UK-based pharmaceutical investors and entrepreneurs. Founded in 1953 by a small group of enthusiastic pharma professionals, Zdravlje’s history is filled with seven decades of production, marketing, and sales worldwide, as well as successful cooperation with the biggest names in the industry like BOEHRINGER, PFIZER, LEDERLE, CLIN MYDI, WELLCOMME, MADAUS, GRÜNENTHAL, Dr DRALLE, SCHWARZKOPF, TRAVENOL, POLYMER TECHNOLOGY... After almost two decades working as a part of Actavis and Teva, launching a new facility in compliance with EU GMP and EHS standards, and receiving several awards in the category of the best quality and performance manufacturing site, from April the 1st 2021, Zdravlje formally starts to operate under the ownership of Frontier Pharma and Baystone Group as an independent pharmaceutical company and a Balkan leader in this industry.